The U.S. has registered over half a million clinical trials since 2000. Here's a look at the business and ethics of human ...

The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

“Discarding unnecessary medication is really important. Exposure or accidental ingestion are concerns, especially if you have ...

Martin Dietrich, MD, PhD, a medical oncologist at the Cancer Care Centers of Brevard and an assistant professor at the ...

The FDA approves a new subcutaneous formulation of amivantamab, enhancing treatment for advanced lung cancer with reduced administration time and improved safety.

J&J has hypothesized that subcutaneous absorption of the drug may potentially enhance immune-mediated anticancer activity.

TAMPA, Fla. — After a whirlwind weekend of shopping Black Friday and Cyber Monday deals, this Tuesday, Dec. 2, is a chance to give back to the community. The Tuesday after Thanksgiving is globally ...

A run-down industrial estate is an unusual place to find one of racing's most prominent owners but, when it comes to Jimmy Fyffe, appearances can be deceiving. The businessman, whose headquarters are ...

Jason Kidd walked off without giving JJ Redick a handshake after the Lakers’ win, creating a viral moment that highlighted rising tension and pushed fans to look closer at Redick’s coaching style. The ...

The state of charitable giving in America is strong and growing on Giving Tuesday this year. “States with larger economies dominate in total charitable giving, while per-capita leaders are shaped by ...

When is the best time to donate to charity? Really, the best time is any time — though, many people are in a particularly generous mood around the holiday season. And, as personal finance reporters, ...

Does the industry actually value Pete Alonso and Cody Bellinger in a significantly different — more appreciative — way than last offseason? That was when Alonso failed to find the market he sought and ...